190 related articles for article (PubMed ID: 17073711)
1. Recombinant factor VIIa, its clinical properties, and the tissue factor pathway of coagulation.
Bosinski TJ; El Solh AA
Mini Rev Med Chem; 2006 Oct; 6(10):1111-7. PubMed ID: 17073711
[TBL] [Abstract][Full Text] [Related]
2. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
3. Recombinant factor VIIa (eptacog alfa): a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders.
Croom KF; McCormack PL
BioDrugs; 2008; 22(2):121-36. PubMed ID: 18345709
[TBL] [Abstract][Full Text] [Related]
4. Comparison of coagulant activity of factor VII and activated factor VII activity assays when used for determination of recombinant activated factor VII levels in plasma.
Scharling B; Nielsen GG; Klitgaard T; Skovsted TA; Møss J; Segel S; Larsen LF
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):677-84. PubMed ID: 17890956
[TBL] [Abstract][Full Text] [Related]
5. New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa.
Veldman A; Hoffman M; Ehrenforth S
Curr Med Chem; 2003 May; 10(10):797-811. PubMed ID: 12678684
[TBL] [Abstract][Full Text] [Related]
6. Variants of recombinant factor VIIa with increased intrinsic activity.
Persson E
Semin Hematol; 2004 Jan; 41(1 Suppl 1):89-92. PubMed ID: 14872428
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of recombinant activated factor VII: an update.
Hedner U
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S105-7. PubMed ID: 16427375
[TBL] [Abstract][Full Text] [Related]
8. Factor VIIa replacement therapy in factor VII deficiency.
Brummel Ziedins K; Rivard GE; Pouliot RL; Butenas S; Gissel M; Parhami-Seren B; Mann KG
J Thromb Haemost; 2004 Oct; 2(10):1735-44. PubMed ID: 15456484
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency.
Gorkom BL; Holme PA; Joch C; Rogosch T; Feussner A; McKeand W; Roberts J; van Heerde W
Hematology; 2020 Dec; 25(1):17-25. PubMed ID: 31852380
[No Abstract] [Full Text] [Related]
10. Monitoring of hemostatic status in four patients being treated with recombinant factor VIIa.
Carr ME; Martin EJ; Kuhn JG; Ambrose H; Fern S; Bryant PC
Clin Lab; 2004; 50(9-10):529-38. PubMed ID: 15481628
[TBL] [Abstract][Full Text] [Related]
11. Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.
Allen GA; Hoffman M; Roberts HR; Monroe DM
Can J Anaesth; 2002 Dec; 49(10):S7-14. PubMed ID: 12546000
[TBL] [Abstract][Full Text] [Related]
12. Recombinant factor VIIa: its background, development and clinical use.
Hedner U
Curr Opin Hematol; 2007 May; 14(3):225-9. PubMed ID: 17414211
[TBL] [Abstract][Full Text] [Related]
13. General haemostatic agents--fact or fiction?
Hedner U
Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145
[TBL] [Abstract][Full Text] [Related]
14. Recombinant factor VIIa for the treatment of congenital factor VII deficiency.
Hunault M; Bauer KA
Semin Thromb Hemost; 2000; 26(4):401-5. PubMed ID: 11092215
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients.
van Geffen M; Mathijssen NC; Holme PA; Laros-van Gorkom BA; van Kraaij MG; Masereeuw R; Peyvandi F; van Heerde WL
Thromb Res; 2013 Jul; 132(1):116-22. PubMed ID: 23731565
[TBL] [Abstract][Full Text] [Related]
16. Recombinant factor VIIa in paediatric bleeding disorders--a 2006 review.
Mathew P; Young G
Haemophilia; 2006 Sep; 12(5):457-72. PubMed ID: 16919075
[TBL] [Abstract][Full Text] [Related]
17. Recombinant factor VIIa: a review on its clinical use.
Franchini M
Int J Hematol; 2006 Feb; 83(2):126-38. PubMed ID: 16513530
[TBL] [Abstract][Full Text] [Related]
18. Use of recombinant factor VIIa for hip surgery in a patient with factor-VII deficiency. A case report.
Gopalan PK; Clohisy JC; Cashen AF; Eby CS
J Bone Joint Surg Am; 2007 Feb; 89(2):389-91. PubMed ID: 17272455
[No Abstract] [Full Text] [Related]
19. Recombinant activated factor VII (rFVIIa, NovoSeven).
Agarwal MB; Patnaik M
J Assoc Physicians India; 2005 Aug; 53():717-20. PubMed ID: 16398083
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIIa: a general hemostatic agent? Yes.
Roberts HR
J Thromb Haemost; 2004 Oct; 2(10):1691-4. PubMed ID: 15456475
[No Abstract] [Full Text] [Related]
[Next] [New Search]
